JP2017520531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017520531A5 JP2017520531A5 JP2016568950A JP2016568950A JP2017520531A5 JP 2017520531 A5 JP2017520531 A5 JP 2017520531A5 JP 2016568950 A JP2016568950 A JP 2016568950A JP 2016568950 A JP2016568950 A JP 2016568950A JP 2017520531 A5 JP2017520531 A5 JP 2017520531A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- antibody
- hydrophobic interaction
- interaction chromatography
- ultrafiltration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462006584P | 2014-06-02 | 2014-06-02 | |
| US62/006,584 | 2014-06-02 | ||
| PCT/IB2015/001643 WO2015186004A2 (en) | 2014-06-02 | 2015-06-02 | Production of fc fragments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017520531A JP2017520531A (ja) | 2017-07-27 |
| JP2017520531A5 true JP2017520531A5 (enExample) | 2018-07-12 |
Family
ID=54337822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568950A Pending JP2017520531A (ja) | 2014-06-02 | 2015-06-02 | Ｆｃ断片の産生 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170129966A1 (enExample) |
| EP (1) | EP3149030A2 (enExample) |
| JP (1) | JP2017520531A (enExample) |
| KR (1) | KR20170040132A (enExample) |
| CN (1) | CN106573973A (enExample) |
| AR (1) | AR100716A1 (enExample) |
| AU (1) | AU2015270152A1 (enExample) |
| BR (1) | BR112016028182A2 (enExample) |
| CA (1) | CA2950241A1 (enExample) |
| IL (1) | IL249274A0 (enExample) |
| MX (1) | MX2016015893A (enExample) |
| WO (1) | WO2015186004A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG191781A1 (en) | 2010-12-30 | 2013-08-30 | Lab Francais Du Fractionnement | Glycols as pathogen inactivating agents |
| BR112015019348A2 (pt) | 2013-02-13 | 2017-08-22 | Lab Francais Du Fractionnement | Métodos para produção de proteína com glicosilação modificada e com sialilação aumentada, para aumentar a atividade de sialil transferase na glândula mamária e para produzir sialil transferase, proteína com glicosilação modificada ou proteína com sialilação aumentada, composição, sialil transferase, mamífero transgênico, e, célula epitelial mamária |
| AU2014217561B2 (en) | 2013-02-13 | 2018-11-15 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Highly galactosylated anti-TNF-alpha antibodies and uses thereof |
| US10611826B2 (en) | 2013-07-05 | 2020-04-07 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Affinity chromatography matrix |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| CA3079118A1 (en) | 2017-11-14 | 2019-05-23 | Bio-Sourcing S.A. | Antibody purification |
| FR3075200B1 (fr) * | 2017-12-15 | 2022-12-23 | Lab Francais Du Fractionnement | Variants avec fragment fc ayant une affinite augmentee pour fcrn et une affinite augmentee pour au moins un recepteur du fragment fc |
| WO2019116096A1 (en) * | 2017-12-15 | 2019-06-20 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Production of fc fragments |
| WO2019183334A1 (en) | 2018-03-21 | 2019-09-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbents, devices and methods |
| CN110669134A (zh) * | 2019-10-15 | 2020-01-10 | 广东菲鹏生物有限公司 | IgM-FC片段、IgM-FC抗体及制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5827690A (en) * | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| EP0690452A3 (en) | 1994-06-28 | 1999-01-07 | Advanced Micro Devices, Inc. | Electrically erasable memory and method of erasure |
| US5843705A (en) | 1995-02-21 | 1998-12-01 | Genzyme Transgenic Corporation | Transgenically produced antithrombin III |
| US6268487B1 (en) * | 1996-05-13 | 2001-07-31 | Genzyme Transgenics Corporation | Purification of biologically active peptides from milk |
| US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
| BRPI0611600B8 (pt) * | 2005-06-17 | 2021-05-25 | Wyeth Corp | método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit |
| EP2815768A3 (en) * | 2006-04-05 | 2015-01-14 | The Rockefeller University | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| KR100897938B1 (ko) | 2007-05-30 | 2009-05-18 | 주식회사 제넥신 | 면역글로불린 융합 단백질 |
| NZ595526A (en) * | 2007-06-14 | 2013-03-28 | Biogen Idec Inc | Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant |
| EP2523677A2 (en) | 2010-01-11 | 2012-11-21 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
| CA2844435A1 (en) * | 2011-08-10 | 2013-02-14 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Highly galactosylated antibodies |
| GB201115665D0 (en) | 2011-09-09 | 2011-10-26 | Univ Leuven Kath | Autoimmune and inflammatory disorder therapy |
-
2015
- 2015-06-02 CA CA2950241A patent/CA2950241A1/en not_active Abandoned
- 2015-06-02 KR KR1020167036698A patent/KR20170040132A/ko not_active Withdrawn
- 2015-06-02 BR BR112016028182A patent/BR112016028182A2/pt not_active Application Discontinuation
- 2015-06-02 US US15/315,809 patent/US20170129966A1/en not_active Abandoned
- 2015-06-02 CN CN201580029461.4A patent/CN106573973A/zh active Pending
- 2015-06-02 AU AU2015270152A patent/AU2015270152A1/en not_active Abandoned
- 2015-06-02 JP JP2016568950A patent/JP2017520531A/ja active Pending
- 2015-06-02 AR ARP150101747A patent/AR100716A1/es unknown
- 2015-06-02 MX MX2016015893A patent/MX2016015893A/es unknown
- 2015-06-02 EP EP15784149.5A patent/EP3149030A2/en not_active Withdrawn
- 2015-06-02 WO PCT/IB2015/001643 patent/WO2015186004A2/en not_active Ceased
-
2016
- 2016-11-29 IL IL249274A patent/IL249274A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012143232A5 (enExample) | ||
| TWI455947B (zh) | 拮抗性對抗人的ｃｄ４０單株抗體 | |
| WO2012009544A3 (en) | Domain insertion immunoglobulin | |
| MX2022001831A (es) | Anticuerpos terapeuticos y sus usos. | |
| PE20220392A1 (es) | Moleculas de union a claudina-6 y usos de las mismas | |
| HK1254357A1 (zh) | 特异性针对过度磷酸化t蛋白的抗体及其使用方法 | |
| JP2014525395A5 (enExample) | ||
| JP2016530533A5 (enExample) | ||
| EP2522724A4 (en) | POLYPEPTIDE MODIFYING METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS | |
| MX2016001601A (es) | Separacion de anticuerpos biespecificos y subproductos de produccion de anticuerpos biespecificos utilizando cromatografia de hidroxiapatita. | |
| JP2013538057A5 (enExample) | ||
| PE20170779A1 (es) | Anticuerpos reactivos con b7-h3, fragmentos inmunologicamente activos de los mismos y usos de los mismos | |
| WO2013177115A3 (en) | Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography | |
| JP2012116856A5 (enExample) | ||
| JP2018505681A5 (enExample) | ||
| EA033433B1 (ru) | Антитела к tau и их применение | |
| AR099625A1 (es) | Anticuerpos de il-21 | |
| RU2014114119A (ru) | Биспецифические анти-egfr/анти igf-1r-антитела | |
| JP2017505620A5 (enExample) | ||
| RU2019111862A (ru) | Новые антитела против фактора xi и их применения | |
| EP4745156A1 (en) | ANTIBODIES CAPABLE OF BINDING TO INTERLEUKIN-31 OR AN ANTIGEN-BINDING FRAGMENT OF IT, ITS PREPARATION PROCESS AND ITS USE | |
| EA202191658A1 (ru) | Антитела против фактора c2b комплемента человека и способы применения | |
| EA202192907A1 (ru) | Моноклональное антитело, которое специфически связывается с gitr | |
| MX2019014105A (es) | Composiciones biofarmaceuticas y metodos relacionados. | |
| WO2012075342A3 (en) | Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody |